Investment Pitches

Pitch Summary:
Roku has established itself as a key player in the streaming industry through its innovative use of the razor-and-blades model, providing low-cost devices to drive platform adoption. However, despite its strong market presence and revenue growth, the company faces significant challenges. The hardware segment operates at a loss, and the overall profitability remains elusive. The competitive landscape is intense, with major players like Amazon, Apple, and Google having much larger budgets. Additionally, the cyclical nature of advertising revenue adds uncertainty to its financial outlook.

BSD Analysis:
Roku's business model relies heavily on advertising revenue, which, while high-margin, is subject to economic cycles that can impact spending and effectiveness. The company's gross margin is constrained by its hardware segment, which contributes negatively to profitability. Despite a robust platform revenue stream with a 54% gross margin, the overall financial performance is hindered by the loss-making hardware division. The company's international expansion could dilute ARPU, as regions outside North America typically generate lower revenue per user. Furthermore, the dual-class share structure consolidates voting power with the CEO, potentially limiting shareholder influence. While the company has a strong cash position, bolstered by a strategic share issuance during the pandemic, its path to profitability remains uncertain. The current valuation suggests a potential downside, with the fair value estimated at $62 per share, below the market price of $70. The possibility of Roku becoming an acquisition target could provide an exit strategy for investors, but the competitive and financial challenges must be carefully considered.

Pitch Summary:
Optex Systems is positioned as a high-quality operator in the defense space, benefiting from its sole-source positioning and backlog dynamics. The company operates at about 30-40% capacity utilization and can potentially double or triple its revenue without major expansion. Optex's revenue is largely driven by sole-source contracts, providing a strong margin and moat. The company is poised for continued double-digit growth, with potential revenue reaching $75 to $100 million in five years. Optex's exposure to expanding defense platforms and increased demand from Europe supports its growth prospects.

BSD Analysis:
Optex Systems is strategically positioned to benefit from increased defense spending and the expansion of military platforms. The company's sole-source contracts provide a stable revenue stream, although they limit demand creation. Optex's ability to scale without significant capital expenditure is a key advantage, allowing it to grow alongside expanding defense budgets. The company's involvement in emerging defense technologies, such as laser filters for high-end drones, adds to its growth potential. Optex's management demonstrates a cautious but competent approach to capital allocation, ensuring sustainable growth without overextending resources.

Pitch Summary:
The author is bullish on Golar LNG, arguing that market fears over Argentina-related political risk are overstated. Two of GLNG’s three floating LNG assets are contracted to Argentina, but he contends that nationalization is unlikely because Argentina depends on these vessels to access lucrative global LNG markets and because the operating structure already includes majority Argentine ownership, including state-owned YPF. He frames the current energy landscape as fundamentally different from 2012, when Argentina nationalized YPF as a net importer; today, strong shale development has changed incentives. Based only on contracted charter revenues, he estimates intrinsic value at about $60 per share, with upside above $100 from commodity-linked tariffs and potential new vessel deployments. Overall, he views GLNG as a favorable asymmetry—limited downside from stable contracts and substantial upside tied to LNG demand and fixed-fee economics.

BSD Analysis:
Golar LNG’s business model combines long-term charter stability with exposure to rising LNG trade flows, especially in emerging markets that lack liquefaction infrastructure. Argentina’s political history justifies investor caution, but the structure of Golar’s FLNG projects—where withdrawal of vessels would materially harm the host country’s export capability—does mitigate expropriation risk. The broader LNG landscape remains supportive: supply constraints, European diversification away from pipeline gas, and the build-out of floating infrastructure create attractive economics for modular liquefaction operators. Nevertheless, concentration risk remains elevated with only a few operating assets, leaving GLNG vulnerable to contract disputes, operational downtime, or cost inflation when deploying future units. Execution on additional vessels or expansions could unlock significant earnings leverage, but financing large FLNG builds requires disciplined capital management. On balance, GLNG offers a differentiated asset base with resilient cash flows, but its long-term upside depends on replicating successful project structures and navigating geopolitical risk effectively.

Actual Post Content:
Took a long position in $GLNG. The biggest perceived risk here is 2 of its 3 vessels are contracted out to Argentina, a country which has a history of expropriating assets pre-Milei (see YPF in 2022). However, even if Argentina goes back to its old ways post-Milei, it wouldn't make much sense for Argentina to nationalize GLNG's project because 1) GLNG could then pull its vessels & Argentina would lose access to the Europe/Asia mkt & be forced to sell the gas domestically where prices are 1/5th that of Europe/Asia, and 2) SESA - the operator of the project - is 75% owned by Argentinean entities and includes state-owned YPF as a 25% owner. Furthermore, it is important to note that YPF was nationalized in 2012 for energy security reasons, and that the energy situation in Argentina is far different today. Back in 2012, Argentina was a net importer of energy, but today that is flipped the other way thanks to Vaca Muerta’s shale gas/oil boom. Based on just the net charter revenue from GLNG's current contracts, I believe GLNG shares are worth around $60. This target does not include the upside from the commodity price linked tariff of GLNG's existing contracts, and also does not assume any new vessels placed under contract. These additional value drivers could drive GLNG shares to >$100. Overall, I think this is a very compelling low downside, very good upside bet.

URL: https://x.com/jaysyoon/status/1925245318875984093

Pitch Summary:
The author presents a bullish but valuation-sensitive view on EVLV, noting that several research firms have recently re-initiated or updated coverage with price targets in the $5.50–$8.25 range. He argues that the company is emerging from a credibility setback, which should reopen the door for institutional capital flows now that filings are current and management has been refreshed. With no near-term share issuance expected, he sees share price action being largely driven by existing holders’ willingness to sell versus new buyers’ demand. He believes short interest is mostly covered, meaning mechanical selling pressure has diminished. While still long, he has trimmed his position as the risk/reward at $6 is less attractive than when the stock traded near $4. Overall, the pitch frames EVLV as a recovery story benefiting from renewed analyst confidence and improved fundamentals under new leadership.

BSD Analysis:
Evolv sits at the intersection of physical security, sensors, and automated screening, a sector benefiting from increasing demand for public-venue safety and labor-efficient detection systems. The company’s growth trajectory depends on converting pilot deployments into long-term contracts while demonstrating reliability and accuracy improvements that address past scrutiny. Analyst re-engagement signals that governance and financial-reporting concerns have begun to normalize, potentially lowering the company’s cost of capital. However, the business still faces execution risk: scaling hardware-plus-software deployments is capital-intensive, competitive, and highly sensitive to sales-cycle timing across municipalities, stadiums, and enterprise venues. Margin expansion will require operating leverage from SaaS-like subscription contracts, which remain in early stages. If new management improves transparency and operating discipline, EVLV could benefit from a multi-year adoption curve, though valuation may remain volatile as the market reassesses credibility, revenue quality, and long-term unit economics.

Actual Post Content:
$EVLV 4 Companies updating/re-initiating coverage Craig Hallum, PT $8.25 Northland, PT $7.50 Lake Street, PT $5.50 Cantor, PT $7.00 Company is coming out of the 'penalty box'. Flow wise, institutional capital will start to come back into the company. With no share issuances on the horizon, price will be dictated by current holders eagerness to hold vs sell to the new demand. Short interest is probably mostly 'fully covered' at this point, the remaining short interest is just basket/index/quant shorts etc. I'm at 4.5% now, down from 6%, since the risk reward at $6 is worse than it was at ~$4. --- 'New Management Drives Impressive Q1 Results And Builds Confidence In The Story. Reiterating BUY And Raising Price Target To $8.25.' 'First Call with New CEO; Healthy Outlook Despite Changes; Increasing Rating' 'Files Delayed 10-Q And Provides Encouraging Guide; Raising PT To $5.50' 'EVLV is Back; Clearer Skies Ahead'

URL: https://x.com/KevinLMak/status/1925232706507452793

Pitch Summary:
The author presents a bullish thesis centered on the rapid expansion of Galaxy Digital’s Helios data-center project. Galaxy already has 800MW approved and is studying an additional 1.7GW, with expectations of receiving further approvals within months. A major 600MW agreement with CoreWeave is projected to generate roughly $900 million in annual revenue at exceptionally high EBITDA margins, and replicating similar terms on additional capacity could push total contracted annual revenue above $2 billion. The company is also evaluating dozens of distressed Bitcoin mining sites for potential conversion into AI data centers, which could significantly expand its infrastructure footprint. Beyond these data-center initiatives, Galaxy maintains several crypto-related businesses—including trading, investment banking, asset management, and tokenization—that provide diversified earnings streams. The core risks involve the massive capital required to build out gigawatt-scale capacity and the need to execute on financing and construction timelines. If Helios scales as planned, the author views Galaxy as having multibillion-dollar upside.

BSD Analysis:
Galaxy’s strategic pivot toward large-scale AI infrastructure places it at the intersection of two powerful themes: hyperscale compute demand and the monetization of legacy crypto mining sites. Long-duration, high-margin offtake agreements—such as the one signed with CoreWeave—suggest meaningful visibility once construction is complete, though the path requires substantial capital deployment and disciplined execution. The company’s willingness to lever up with an 80/20 debt-equity mix introduces financial-risk sensitivity to interest-rate trends, construction delays, and counterparty performance. At the same time, converting distressed mining sites into AI-ready campuses could give Galaxy access to lower-cost power and land, potentially creating a competitive moat versus traditional data-center operators. The crypto-financial services franchise provides incremental optionality but remains correlated with digital-asset cycles. Ultimately, the investment case hinges on Galaxy’s ability to transform Helios into a scaled AI compute hub while managing a multibillion-dollar capex cycle without overruns or liquidity strain.

Actual Post Content:
Galaxy has become one of my largest positions and I am extremely excited about it's potential, here is the bull case for $GLXY this year: --> Currently Galaxy has 800MW of approved power at Helios, they have 1.7GW under study and expect to receive approval in tranches, with the next tranche set to be approved in 'single digit months' according to the last earnings call. --> Of the current 800MW approved, they have entered into an agreement with CoreWeave $CRVW for 600MW on a 15 year contract where they expect to earn $900M in average annual revenue at 90% EBITDA margins. --> If Galaxy gets another 800MW tranche approved from ERCOT (Texas energy council) and they contract the remaining 1000MW out under similar terms to CoreWeave we are talking about $2.4B in average annual revenues! I am speculating but I think this has the chance to happen within 2025. --> @RHouseResearch made this fantastic table in his most recent report showing the different levels of equity value based on how much Galaxy can get under contract and what multiples comparable data center companies trade at. There seems to be a lot of upside from Galaxy's current ~$8.5B market cap if they can execute at Helios. --> During the last earnings call Galaxy's management team discussed 40+ different BTC mining sites they are looking at to potentially acquire and convert into AI data centers. This could be a HUGE opportunity for Galaxy if they can acquire some distressed mining assets or partner with Bitcoin Miners who need financial support & the expertise + relationships that Galaxy has developed at Helios and with CoreWeave. --> This also doesn't ascribe any value to the rest of Galaxy's business which is centered around crypto, they operate a few different business lines here: - A trading desk where they offer spot, derivatives, OTC trading, lending and structured products - Investment Banking services within crypto/web3/blockchain (helped facilitate the sale of Bitstamp to Robinhood) - Asset management where they have $7B in AUM - Staking/Tokenization services Risks: --> The build out of the current 600MW is expected to complete in phases between 2026-2027, and building out 1.6GW in capacity might extend that timeline to lets say 2028/2029. Building this out will cost ~$11/12B and they are planning to finance it with 80% debt and 20% equity - they need to execute perfectly here and also secure financing. --> I don't think demand for data centers will be an issue when you look at the MASSIVE capex spend from all the big tech companies and the exponentially increasing usage of AI. Overall Galaxy is a leader in Crypto and Helios could end up being one of the largest AI data center in the United States. I am long $GLXY. With $BTC and $CRVW hitting new all time highs today I am super excited for $GLXY. This research piece is a must read, with a near term target of $32B (~4x upside from here) if Galaxy executes on the build out of their Helios data center.

URL: https://x.com/floodcapital/status/1925645081811271797

Pitch Summary:
The thesis is a turnaround long anchored by the hiring of Brian Niccol (ex-CMG/Taco Bell) to fix execution and re-accelerate growth. The author frames today’s setup as rhyming with Howard Schultz’s 2008 return: first stabilize the store experience, then let financials follow with a lag. Mobile Order & Pay (~30% of U.S. sales) created throughput “mosh pits” and degraded in-store vibes; Niccol’s early focus is re-sequencing orders and channel specialization, including licensing Empower Delivery software and hiring its founder, Meredith Sandland, to run store development. The new playbook centers the barista (“green apron”) and customer, tightens in-store policies, and re-brands around “Starbucks Coffee Company” to rebuild premium perception squeezed between value QSR and artisanal cafes. Cost action has started (1,100 corp roles cut) while marketing and product cadence are being refreshed; near-term specifics are light, but that mirrored Schultz’s early communications before results inflected. Incentives are powerful: Niccol forfeited sizable unvested CMG options for an SBUX package with 60% PRSUs tied to relative TSR, plus annual EPS/comp metrics—directly aligning pay with a real operating recovery. Historically, SBUX expanded EBIT margins from ~11% pre-GFC to ~20% over the following cycle; the bet is that smoothing MOP and restoring service can push margins back toward the mid-to-high-teens with upside. Optionality includes higher kitchen throughput unlocking a larger steady-state revenue base, international product launches, and multiple expansion if early proof points land. Risks include constrained pricing power if the brand stays “stuck in the middle,” macro softness hitting discretionary traffic, and the firm’s mixed record with non-founder CEOs. Still, this is a high-ROIC global brand with cash-generative unit economics; execution fixes, not reinvention, are the crux. If evidence of traction shows up in comps, throughput, and NPS, the market should re-rate the equity.

BSD Analysis:
A founder-style playbook with a proven operator: Starbucks doesn’t need a new category; it needs to de-bottleneck MOP, re-center service, and let the existing unit model compound again. Niccol’s incentives, early org moves, and the Empower Delivery toolkit target the true constraint—throughput—while the balance sheet and brand afford time. Watch sequential improvements in wait-time accuracy, peak-hour throughput, and U.S. traffic; those should precede margin repair and multiple expansion.

Pitch Summary:
The pitch is a long on Comtech driven by a likely near-term sale of its Public Safety / NG911 business that could reset the capital structure and surface substantial equity value. The NG911 unit does ~$220m revenue and ~$45m EBITDA / ~$32m FCF proxy and has sticky, regulated, high-moat contracts; precedent comps (Intrado @ ~22x, Motorola ~21x) suggest double-digit EBITDA multiples are realistic even in a tougher tape. The author frames a valuation range of ~$400m (9x) to ~$800m (18x) for the asset; at the low end, proceeds would largely clear senior and subordinated debt and preferreds, de-risking the remain-co, while at the high end shareholders could see ~$6.8/share cash plus additional remain-co value. Management has already begun a strategic review, sold non-core pieces, and refinanced mismatched debt; the new CEO (Ken Traub) specializes in complex stakeholder turnarounds and the NG911 head (Jeff Robertson, ex-Intrado) is financially incentivized to deliver a sale ≥£500m EV within 18 months. Timing catalysts line up: lender forbearance/covenant dates, NENA (the key public safety conference) in June, and an “independent director” deadline in the credit agreement—all pushing toward an announcement before FQ3 results. Post-sale, the Satellite/Space/Defense remain-co (Troposcatter, modems, amplifiers, engineered systems) can focus on margin repair under Dan Gizinski; Tropo alone may be worth $100m+ EV, and normalized segment sales of ~$250–300m support further upside if execution improves. Scenario math indicates highly asymmetric payoffs from today’s ~$2 stock: bull case ~$11/share (cash plus remain-co), mid case ~$9–10, bear case still ~>$7 if deal clears at 9x and warrants/make-wholes are managed. Risk is mostly execution and capital-structure friction—preferred economics (make-wholes, $8 strike warrants) and lender dynamics could siphon proceeds or delay closing, and a sub-9x print would reduce deleveraging. Even so, buyer appetite appears real (recent 8–14x tower/infra-like prints; NG911 is strategic to MSI/Intrado/Axon/PE), and the asset continues to win RFPs despite parent distress—supporting the thesis that value is in the parts. Overall, this is a catalyst-driven breakup where the sale of NG911 is the unlock, deleveraging the balance sheet and leaving equity with material claim on cash and a cleaner core.

BSD Analysis:
Deep breakup value with a hard catalyst: selling NG911 at even a floor 9x multiple likely de-risks or clears debt; at mid-teens multiples, equity could be worth multiples of today’s price after cash proceeds and a re-rated Space/Defense remain-co. Governance/creditor frictions and preferred make-wholes are the swing factors, but timeline pressure (covenants, NENA) and buyer universe raise odds of a near-term print.

Pitch Summary:
The merger between Amcor and Berry Global creates a dominant global packaging leader with durable earnings, margin expansion, and mid-teens EPS growth potential—offering 50% upside as synergies are realized and valuations normalize.

BSD Analysis:
Amcor (AMCR), the world’s largest producer of plastic packaging, is merging with Berry Global to form a $28B enterprise commanding unmatched scale and cost advantages. The combined entity will derive ~60% of revenue from flexible packaging and ~40% from rigid containers, serving defensive end markets like food, beverages, and healthcare. Amcor’s moat lies in scale-driven purchasing power and technical expertise—further enhanced by Berry’s complementary assets—allowing for high returns on invested capital (mid-20%) and steady cash flow. The merged firm expects to grow revenue low single digits and EPS mid-teens through 2028, driven by ~$400M+ of synergies and improved operating leverage. Environmental concerns over plastics are overstated; Amcor’s products are largely non-substitutable and increasingly recyclable (90–100% of offerings). Trading at just 11.5x NTM EPS, the stock offers an appealing risk/reward profile, with intrinsic value estimated 50% higher as integration progresses and margins expand. Key catalysts include synergy delivery, accelerating EPS growth, and investor recognition of Amcor-Berry’s superior scale and defensiveness.

Pitch Summary:
Despite recent share price weakness due to macroeconomic concerns, Thermo Fisher Scientific remains fundamentally strong. The company's long-term growth prospects are intact, driven by its critical role in the healthcare and research sectors. The current valuation presents a compelling opportunity for investors.

BSD Analysis:
Thermo Fisher's recent share price decline is largely attributed to macroeconomic factors and policy concerns, which are unlikely to have a lasting impact on its business. The company's robust product portfolio and strategic acquisitions position it well for sustained growth. With a reduced profit outlook already priced in, any easing of policy concerns could provide upside to current guidance. Trading at a discount due to temporary headwinds, Thermo Fisher offers a favorable risk-reward profile for long-term investors.

Pitch Summary:
The author argues that Airbnb ($ABNB) delivered a quarter consistent with prior trends, reinforcing a “stuck” narrative where growth continues to decelerate and margin expansion is paused due to reinvestment. Nights booked grew 8% YoY—the slowest rate outside COVID—while net adds continue to trend down structurally. ADR and take rate showed limited upside, constrained by mix shift to lower-priced emerging markets and competitive dynamics versus hotels and alternative platforms. The new Experiences and Services redesign is viewed as the most promising strategic lever, but its revenue impact remains unproven. Valuation appears reasonable on free cash flow but stretched on GAAP EPS, particularly as FCF benefits from working-capital tailwinds that fade with slower growth. Capital returns have been meaningful, though largely offsetting stock-based compensation. Overall risk/reward is described as fair but uninspiring absent a growth reacceleration.

BSD Analysis:
The global accommodations industry has matured into a highly penetrated, competitive ecosystem where incremental growth is increasingly contested. Airbnb’s competitive position remains strong in alternative lodging, but its growth ceiling is becoming more visible as supply expansion slows and hotel parity improves. Experiences and services represent a logical adjacency with strategic fit, yet monetization faces classic two-sided marketplace challenges around discovery, quality control, and supplier activation. Structurally, Airbnb’s margin profile is already best-in-class, limiting further operating leverage without new revenue layers. The primary secular risk is normalization toward travel GDP growth rather than platform-style hypergrowth. Valuation embeds durability but not acceleration, making multiple expansion unlikely without evidence that Experiences meaningfully lifts take rate or engagement. Downside appears limited by cash generation and buybacks, but upside requires a clear second growth engine. In that context, Airbnb increasingly screens as a high-quality compounder transitioning into a steady-state travel utility rather than a disruptive growth platform.

Actual Post Content:
$ABNB reported a qtr consistent w/ prior trends. Story: Kind of stuck. Growth continues to slow and margin expansion on hold while they invest in growth initiatives. New experiences / services offering is very sleek and seems to be value-add – will have to see whether it resonates. Numbers: Kind of stuck. I’m on top of street. Risk / reward: Kind of stuck in reasonable+ territory. Reasonable to cheap on FCF. Reasonable to pricey on EPS. Trades at 33x my 2026 GAAP EPS / 19x FCF. FCF excludes stock comp and includes working capital tailwind that diminishes as growth slows. Quarter Nights booked were 143m up 8% yy which is slowest growth outside COVID. Net adds of 32.1 down from 33.8 last Q1 and 32.9 the Q1 prior. Net night adds by year: -2019: 76.6 -2022: 93.1 -2023: 54.5 -2024: 43.3 -2025: 38.6? The ability to grow the network / business just continues to face pressure – likely a function of value prop vs hotels, market penetration, and perhaps some degree of competition (though $BKNG vacation rental skews to Europe). The app continues to improve along with ancillary services, but they just can’t seem to reinvigorate growth. The new experiences / services functionality is very well designed and does seem interesting. Does seem like this redesign is the most promising step as far as building the experiences business. Otherwise challenging for visitors to book all these things and tough for suppliers to connect with this visiting demand. Certainly seems like it opens up potential tourist spend -> home chef, massage, photoshoots, etc. Something to track – wonder if they should have a “Host recommended” section after you book your rental where you can see what local experiences / services the host endorses. Back to the qtr: ADR was up 1% yy cc. Take rate of 9.3% down 10 bps yy. Hard for them to move ADR very much given mix shift to emerging markets which are lower priced, and take rate likely can’t go much higher w/o uptake of additional services – particularly challenging to just take up price given declining growth rates (as that would negatively impact supply growth). They continue to show operational discipline but also did so well that margins have to be flattish this year to accommodate investment expense. EBITDA margin of 18.5% down from 19.4% last Q1. GAAP OM of 1.7% down from 4.7% last Q1 (Q1 is low point). Capital is sort of being returned. They have spent 6.7b over the past 2 years to decrease sharecount by 5%. Not bad – more than offsetting the 2.9b in stock comp over that same period. Guidance was for growth to slow down further in Q2 given Easter / Leap Year comps. EBITDA margins for the year still expected to be >34.5% vs 36.2% last year.

URL: https://x.com/TechFundies/status/1924596413461365180

Pitch Summary:
The author argues that Teqnion ($TEQ) is facing a serious governance red flag following the quiet January 2025 appointment of a new CEO at subsidiary Eloflex. The appointed CEO reportedly has no prior corporate management experience and is in a long-standing personal relationship with Teqnion’s Deputy CEO, a relationship that predates the appointment. The author highlights the absence of disclosure, explanation, or apparent governance safeguards around what appears to be a related-party appointment. This is framed not as a minor HR lapse but as a material C-suite governance failure at a controlled subsidiary. The situation is compounded by broader concerns around transparency, including undisclosed litigation, CEO changes, and lack of impairment testing. The pitch suggests that what has historically been perceived as a “quality compounder discount” may in fact reflect mounting governance risk.

BSD Analysis:
Conglomerate investment models rely critically on capital allocation discipline, trust in management, and strong governance to justify decentralized autonomy. Teqnion’s competitive positioning as a Constellation-style operator is undermined if governance standards fall below public-market expectations. Perceived nepotism at the subsidiary level raises questions about board oversight, internal controls, and merit-based leadership selection—all essential to sustaining long-term ROIC. In Sweden, where corporate governance norms emphasize transparency in related-party matters, failure to disclose is itself a reputational risk. Even if operational impact is limited short term, governance discount can persist and widen once credibility is impaired. The key risk is not a single appointment but precedent: erosion of trust can impair deal flow, talent retention, and valuation multiple simultaneously. Valuation compression in such models tends to be nonlinear once investor confidence breaks. Unless addressed clearly and credibly by the board, this issue could shift Teqnion from a compounder narrative to a governance-risk re-rating.

Actual Post Content:
🚨 Conflict of interest alert at $TEQ / Teqnion 🚨 In Jan 2025, @linnea_moller was quietly appointed CEO of Eloflex — a Teqnion subsidiary. She has zero corporate experience. Her last job? Assistant principal at a Stockholm high school. Why was she hired? Because she lives with @CXODanielZ — Deputy CEO of Teqnion. $teq They’ve shared a home since 2022. A personal relationship, predating the appointment. And yet: no disclosure, no explanation, no governance. This isn’t a minor HR issue. It’s a C-suite appointment at a Teqnion-controlled company… …and it reeks of nepotism and governance failure. Swedish corporate code calls for transparency in related-party relationships. Where is it? $teq @Sugrorsmannen are you overseeing all of this? Hey @eldsjal — that Teqnion “discount” isn’t aging well. As a shareholder, don’t you think it’s time to demand answers? No impairment testing, undisclosed litigation, CEO swaps (including the girlfriend?)… This isn’t Constellation, it’s a house of cards. $TEQ

URL: https://x.com/hughes10852/status/1924771732537176371

Pitch Summary:
The author argues that Iveco Group ($IVG) is approaching a value-unlocking inflection as it moves forward with the planned separation of its Defence business, either via spin-off or outright sale. Management has disclosed receipt of preliminary expressions of interest from strategic buyers, highlighting tangible transaction optionality rather than a theoretical breakup. While Iveco trades at ~8.5× forward earnings, its Defence segment is growing faster and earning higher margins than the rest of the group. In the current European defense re-rating environment, the author sees a clear mismatch between group valuation and the implied value of the Defence assets. Either transaction path is expected to surface this hidden value.

BSD Analysis:
European defense industry structure has shifted materially, with national security priorities, NATO spending commitments, and supply-chain sovereignty driving premium valuations for scaled, proven platforms. Iveco Defence’s competitive position benefits from established OEM capabilities, long customer relationships, and exposure to structurally rising land-systems spend, differentiating it from cyclical commercial vehicle peers. The conglomerate structure obscures this quality, subjecting the Defence unit to an inappropriate industrial multiple. A separation would sharpen capital allocation, improve strategic focus, and likely attract either defense primes or financial sponsors willing to pay sector-appropriate multiples. Key risks include execution complexity, labor and political considerations in Europe, and timing relative to budget cycles. However, the presence of inbound strategic interest materially de-risks the outcome. Valuation suggests the market is still anchoring on group averages rather than sum-of-the-parts logic. If the Defence business is spun or sold at peer multiples, Iveco equity could see meaningful re-rating even without improvement in the core industrial segments.

Actual Post Content:
Iveco $IVG is moving forward with its planned separation of its Defence business via a spin-off. The company also mentioned that it 'has recently received preliminary expressions of interest from potential strategic buyers for its Defence business'. This one should be interesting. European + defence - just look at the valuation some of these companies are trading. $IVG is trading at ~8.5x forward pe, meanwhile its Defence segment has been growing much more rapidly than the rest of the business, and at higher margins. Spin or sale, this should unlock some value.

URL: https://x.com/ToffCap/status/1924827573025919320

Pitch Summary:
The thesis is a long on Deckers Outdoor, a structurally advantaged footwear and lifestyle company anchored by two high-growth, high-margin global brands—Hoka and UGG—that together form one of the strongest brand portfolios in retail. Despite a 40% YTD pullback on tariff fears and soft low-income U.S. demand, Deckers trades at ~16x forward EPS (below its 5- and 10-year averages of 24x and 20x, respectively) with a clean balance sheet (>$2B net cash) and sustained double-digit growth. Hoka (~$3B run-rate sales) continues to compound globally with a “pull model” built on authentic performance credibility, limited wholesale expansion, and disciplined pricing—positioning it to become the next mainstream athletic franchise behind Nike, Adidas, and On. Meanwhile, UGG (~$3.1B run-rate) has successfully transformed from a cold-weather boot brand into a year-round lifestyle name spanning sneakers, sandals, and clogs, growing double digits internationally while maintaining scarcity-driven sell-through. Management’s long-term strategy prioritizes full-price selling and brand health over near-term volume, sustaining gross margins above peers (Hoka DTC mix ~30%, UGG ~50%) and ROIC in the top decile of consumer discretionary. Comparables underscore underappreciated value: ONON trades at 51x forward EPS, Adidas 22x, Nike >30x, and RL 23x, versus DECK’s 16x. Even with conservative assumptions of high-single to low-double-digit revenue growth and mid-teens EPS CAGR through the decade, DECK screens as a compounder with a long runway in global footwear and lifestyle. Risks include tariff escalation, UGG growth normalization, or Nike regaining share in performance running. But brand equity, global momentum, and a fortress balance sheet offer insulation, while any easing in trade or consumer fears could re-rate shares materially.

BSD Analysis:
A rare two-engine growth story in retail: Hoka’s rapid scale-up and UGG’s reinvention underpin sustained double-digit compounding with best-in-class margins and pristine balance sheet optionality. Current valuation reflects transient macro and tariff fears, not structural brand strength. Even modest reversion to historical multiples or resolution of trade overhang could drive 30–50% upside over 12–24 months.

Pitch Summary:
Faked assembly and testing, staging a non-compliant transition flight, stalling FAA certification at ~15%, and hiding patent-warned catastrophic vibration risks.

BSD Analysis:
Archer Aviation trades on eVTOL hype with commercialization still years away. Shorts highlight long certification timelines, uncertain unit economics, and high cash burn. Partnerships with airlines provide optionality but little near-term revenue. Financing needs before 2026 likely mean material dilution.

Pitch Summary:
The author @Zerosumgame33 presents a catalyst-dense bullish thesis for Calumet, arguing that multiple near-term events could materially reprice the equity upward. First, he expects the upcoming RVO proposal to come in higher than consensus, which would strengthen RIN pricing and improve the economics around Calumet’s renewable diesel and SAF strategy. Second, he anticipates Russell 2000 inclusion, a flow-driven catalyst that increases institutional ownership and liquidity. Third, he believes an imminent asset sale will retire the remaining $200M of 11% 2026 notes—eliminating the last major near-term maturity, reducing interest expense by $22M, and removing a long-standing equity overhang. Fourth, he sees room for Calumet to raise pari-passu debt and use those proceeds to refinance a $375M intercompany loan, further deleveraging the parent entity. Finally, he expects Calumet to announce its first SAF offtake agreement for phase one of its Montana project, which would validate demand and provide more forward revenue visibility. Combined, these catalysts target leverage, liquidity, cost of capital, and commercial validation, forming a near-term setup that he believes the market is underappreciating.

BSD Analysis:
Calumet sits at a strategic inflection point where the trajectory of its balance sheet and the credibility of its SAF platform will determine valuation normalization. The partnership’s historical burden—high-cost debt, complex capital structure, and refining cyclicality—has long obscured the intrinsic value of its specialty products business. Retiring the 2026 notes would be a transformative step, as it removes refinancing uncertainty and signals improved creditor confidence, but hinges on asset-sale execution and pricing in a still-fragmented market for midstream and downstream assets. The SAF project is potentially high-return but exposed to policy volatility: RVO settings, LCFS spreads, feedstock availability, and long-term offtake pricing all influence earnings durability. Securing binding SAF offtakes would materially derisk the commercialization pathway, but investors will require clarity on margins, capex phasing, and long-term returns before fully underwriting the thesis.
Moreover, while R2K inclusion adds mechanical demand, it does little to address structural issues such as Calumet’s heavy reliance on external financing, the need for consistent free cash flow generation, and susceptibility to commodity spreads. A key determinant of long-term multiple expansion will be whether Calumet can sustainably transition from a leveraged MLP into a specialty/renewables hybrid with more predictable recurring revenue. The near-term catalysts highlighted by the author could unlock meaningful upside, but the true rerating depends on operational reliability at Montana Renewables, prudent capital allocation, and a clear pathway toward a lower cost of capital.

Actual Post Content:
$CLMT 5 key things I'm expecting in the near term/Q2 that should get the equity up: 1) RVO proposal this week. I think the number surprises to the upside. Rins will rip higher. 2) R2K index inclusion on 5/23 3) Asset sale. I think the remaining $200M on the 11% 2026s get taken out w/ proceeds. Taking out the last near-term maturity is a huge equity overhang relief. This will save another $22M in cash interest - the market will see that this interest savings is also the newly estimated capex plan for phase 1 of SAF expansion (😂) 4) Raise 'pari-passu debt' for a significant portion of the $375M intercompany loan de-leverages parentco. 5) Sign & announce first SAF offtake agreement for phase 1

URL: https://x.com/Zerosumgame33/status/1924472783737692669

Pitch Summary:
United Parks & Resorts presents a compelling value and strategic opportunity, with activist-led execution, industry-leading margins, and potential for transformative value creation through a merger with Six Flags.

BSD Analysis:
United Parks & Resorts (PRKS), formerly SeaWorld, has been transformed under Hill Path Capital’s leadership into one of the most profitable regional theme park operators, with EBITDA margins now in the 40% range and attendance levels back to pre-COVID norms. The company’s disciplined capital allocation, cost control, and pricing strategy have doubled EBITDA since 2017 to ~$700M in 2024. Despite this improvement, PRKS trades at only ~7x EBITDA amid investor concerns over capital returns, governance control, and competitive headwinds from Universal’s upcoming Epic Universe in Orlando. The write-up argues that a merger between PRKS and Six Flags (FUN) could unlock massive shareholder value by creating a $1.8B EBITDA regional park powerhouse with reduced leverage (from 5x to <4x), improved diversification, and $150–200M of annual free cash flow synergies. The combined entity would generate over $650–700M in FCF by 2026, de-lever to 3x EBITDA, and have the ability to initiate significant buybacks. At a 9x multiple, the pro forma valuation implies a $12B market cap—nearly double the current combined value. With Scott Ross’s proven track record, margin tailwinds, and imminent capital allocation update from the board, PRKS offers a clear catalyst path for substantial upside.

Pitch Summary:
TeamViewer SE is a misunderstood, cash-generative remote access software company trading at <10x 2026 EPS, poised for re-rating as enterprise growth, margin recovery, and the 1E acquisition integration drive mid-teens earnings and FCF growth.

BSD Analysis:
TeamViewer SE (TMV GY) provides remote access, support, and device management software with a strong global brand and sticky recurring revenue base. Once viewed as a COVID beneficiary, the company is transitioning from SMB-focused to enterprise-led growth, with enterprise revenue compounding ~30% annually since 2021. The December 2024 acquisition of 1E, a Digital Employee Experience (DEX) software firm, broadens TeamViewer’s platform into proactive IT monitoring and endpoint optimization—creating substantial cross-selling and AI-enhanced automation opportunities. Despite leverage rising to ~3x, the deal accelerates top-line growth and adds strategic differentiation. Meanwhile, the company’s legacy SMB business (~70% of sales) remains stable, while cost efficiencies and reduced marketing spend (notably post-Manchester United sponsorship) are restoring EBITDA margins to the mid-40s. Trading at 8.5x forward EV/EBITDA and yielding 14% FCF, TeamViewer is significantly undervalued relative to peers. With insider buying, buybacks reducing share count 15% since 2022, and improving sentiment around enterprise traction, the stock offers a compelling setup for 50%+ upside.

Pitch Summary:
Macompta.fr is a highly profitable French SaaS compounder with >30% revenue CAGR, 45%+ ROE, and a long runway ahead as France mandates e-invoicing—trading at just 15x 2025 EV/EBITDA.

BSD Analysis:
Macompta.fr (MLMCA.PA) is a French cloud-based accounting, tax, and payroll SaaS provider serving micro and small businesses (30% CAGR for eight years with ROE exceeding 45%, all self-funded and without dilution, stock-based compensation, or debt. Its platform—covering accounting (61% of revenue), tax, payroll, billing, and fixed asset management—has ~25,000 users and >80% recurring subscription revenue. Macompta differentiates itself with simplicity, affordability, and an integrated product suite that minimizes churn and training needs. Growth prospects are exceptional: cloud accounting adoption in France remains low (~33%), while government-mandated e-invoicing (2026–2027) will compel millions of businesses to adopt compliant digital systems. Macompta is applying for PDP (Partner Dematerialization Platform) certification, positioning it as a key beneficiary of this structural shift. Temporary 2024 margin pressure from non-recurring costs (listing, HQ construction, marketing) will normalize in 2025, with EBITDA margins returning toward 35%. The company plans to up-list to Euronext Growth within 2–3 years, which should boost liquidity and visibility. With continued 30–35% growth, 45%+ ROE, and regulatory tailwinds, MLMCA represents a rare high-quality European microcap compounder poised to triple by 2028.

Pitch Summary:
Exagen Inc. is an undervalued molecular diagnostics turnaround story focused on autoimmune diseases, with a proven management team, accelerating growth, and strategic M&A potential—offering multi-bagger upside as profitability and adoption inflect.

BSD Analysis:
Exagen (XGN) develops proprietary autoimmune diagnostic tests under its AVISE® brand, led by its core product AVISE CTD, which provides superior accuracy in detecting lupus and related connective tissue diseases. The company serves a large, underserved market where effective diagnostics benefit patients, providers, and payers by enabling faster, cheaper, and more accurate diagnosis of autoimmune disorders. Under new CEO John Aballi—a successful diagnostics executive who previously sold Decipher to Veracyte—Exagen has undergone a major turnaround, shifting focus to its core autoimmune franchise, improving ASPs, expanding reimbursement, and reducing annual cash burn from ~$35M to near breakeven. AVISE adoption is accelerating, supported by new T-cell biomarkers, kidney disease applications, and upcoming rheumatoid arthritis markers, while biopharma partnerships offer an incremental growth engine. Trading at only ~1.9x trailing revenue versus peers at 4–11x, Exagen’s differentiated technology, proven management team, and growing strategic relevance to potential acquirers like Labcorp position the stock for significant upside. With 20%+ projected revenue CAGR and improving margins, XGN offers a compelling setup for a re-rating and potential strategic sale over the next 12–24 months.

Pitch Summary:
“New jockey” turnaround of a chronically discounted holdco via radical HQ cost cuts, accelerated buybacks, asset sales of Bozzetto & Cortland at ~7x EBITDA, and recycling into cheap UK cash generators that can use Aimia’s ~C$1B tax shield.

BSD Analysis:
Aimia has long traded like a governance-tainted “shitco,” but the thesis argues the setup changed with activist Rhys Summerton (Milkwood) becoming executive chair in Mar-25, declining a salary, and buying ~6% of shares. He’s applying a familiar playbook: slash holding-company costs (guided to ~C$10m in 2025 vs C$27–34m in 2022–24), harden capital allocation, and lean into aggressive buybacks. The plan is to sell Bozzetto (specialty chemicals, Italy/US) and Cortland/Tufropes (ropes & netting) around 7x EBITDA and redeploy into listed UK microcaps with US/Canada operations to monetize Aimia’s ~C$1B NOLs. Management reaffirmed 2025 guidance implying ~C$90m EBITDA from the two businesses before ~C$10m holdco costs; on 7x EV/EBITDA, author marks NAV at ~C$3.80/sh, with upside to ~C$4.90/sh if part of the NOL is realized. Milkwood’s track record (e.g., Argent Industrial activism with deep buybacks and overhead pruning) is presented as the template for value unlock. Monthly repurchases underscore perceived mispricing and create downside support while assets are marketed. Key debate is execution: finding buyers at fair multiples and then sourcing simple, cash-rich UK targets where cost and capital discipline can move the needle. The bet is explicitly on the “jockey,” with insider alignment (personal capital, no salary) mitigating classic holdco agency risk. Risk factors include failed divestitures, overpaying for new platforms, and macro/tariff sensitivities in current assets. If sales clear anywhere near the indicated multiples and overhead comes out as guided, the holdco discount should compress. With incremental catalysts (renewed NCIB, sale announcements), the author sees a credible path to NAV realization within 12–24 months.